Business / Finance

RSS

Ansell reaches agreement to acquire BarrierSafe Solutions International

Ansell Limited, a global leader in protection solutions, today announces that it has reached an agreement to acquire BarrierSafe Solutions International ("BarrierSafe"), a leading North American provider of single-use gloves, for a total consideration of approximately US$615 million, subject to certain adjustments (the "Acquisition"), from Odyssey Investment Partners and others.

26 Nov 2013

CHMP adopts positive opinion for ABRAXANE with gemcitabine for treatment of metastatic pancreas

Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation, today announced that the European Medicines Agency's: Committee for Medicinal Products for Human Use has adopted a positive opinion for ABRAXANE (paclitaxel formulated as albumin bound nanoparticles, or nab-paclitaxel) in combination with gemcitabine for first-line treatment of adult patients with metastatic adenocarcinoma of the pancreas.

25 Nov 2013

Nutranomics joins Genesar Nutraceuticals to acquire worldwide licence for GenEpic

Nutranomics, Inc. is pleased to announce that the Company has completed a Licence Agreement with Genesar Nutraceuticals, LLC to acquire the worldwide exclusive marketing and distributing rights to GenEpic, a natural therapeutic treatment formula currently the subject of an IRB reviewed phase II human clinical study on prostate cancer treatment and recovery.

25 Nov 2013

Patient Safety Technologies announces closing of $5 million senior secured term loan

Patient Safety Technologies, Inc. today announced the closing of a $5 million senior secured term loan. At close, $4 million of the term loan was funded. The Company has the ability to draw an incremental $1 million under the term loan, subject to certain conditions. The five-year term loan matures in 2018 and bears interest at 13% per annum.

22 Nov 2013

Covagen, TRL expand research collaboration to generate bispecific FynomAb

Covagen and Tanabe Research Laboratories U.S.A, Inc., a fully owned subsidiary of Mitsubishi Tanabe Pharma Corporation, today announced that they expanded their strategic research collaboration. MTPC and TRL have nominated a first bispecific FynomAb for formal preclinical development which triggered an undisclosed milestone payment. MTPC and TRL also exercised an option for a second bispecific FynomAb program based on the parties' research and licensing agreement signed in October 2012.

21 Nov 2013

Vect-Horus, AAA form scientific collaboration to open new avenues in treatment of brain diseases

Vect-Horus, a French company specialized in the development of vector molecules for the central nervous system, announces today it has signed a scientific collaboration agreement with Advanced Accelerator Applications, a fast growing international player in Molecular Nuclear Medicine. The financial terms of the deal have not been disclosed.

20 Nov 2013

RAS, Sutter Health join to provide medical care and services for patients in greater Sacramento region

Sutter Health and Radiological Associates of Sacramento have agreed to join forces in providing diagnostic imaging and radiation oncology services across the greater Sacramento region.

20 Nov 2013

LabStyle Innovations, InnoMed ink distribution agreement for Dario blood glucose monitoring device

LabStyle Innovations Corp., developer of Dario, a cloud-based, mobile health platform for diabetes and related blood glucose monitoring, announced today that it has entered into an exclusive agreement with InnoMed Ltd. to distribute the Dario diabetes management platform's blood glucose monitoring device in New Zealand. The terms of the agreement were not disclosed.

20 Nov 2013

AGA, Covidien partner to improve lives of people struggling with digestive diseases

The American Gastroenterological Association Institute announced today that Covidien, a leading global provider of health-care products, recently agreed to expand its corporate grant to the AGA Institute.

19 Nov 2013

Curie-Cancer inks partnership agreements with Meiogenix to develop SpiX technology

Curie-Cancer, the body responsible for developing Institut Curie's industry partnership activity, today announces two three-year partnership agreements with Meiogenix, a French SME. Meiogenix develops SpiX technology under license from Institut Curie and Institut National de la Recherche Agronomique.

19 Nov 2013

New range of recombinant Fab monoclonal antibodies launched by BBI Solutions at Medica 2013

BBI Solutions, a world leader in immunoassay development and contract manufacturing, recently launched its unique range of Recombinant Fab Monoclonal Antibodies at the American Association for Clinical Chemistry’s (AACC) Annual Meeting and Clinical Lab Expo, on July 28-August 31, 2013, in Houston, Texas.

19 Nov 2013

Argos Soditic-managed funds announce acquisition of Cisbio Bioassays

The funds managed by Argos Soditic announce the acquisition, together with the management, of Cisbio Bioassays. This cutting-edge biotechnology company is the leader in the field of products and services for human in vitro diagnostics and pharmaceutical research.

18 Nov 2013

Eisai partners with NewBridge Pharmaceuticals to market Halaven drug in Middle East

Eisai announces today that Halaven (eribulin) will be marketed in selected countries within the Middle East region through a new partnership between Eisai EMEA (Europe, the Middle East, Africa, Russia and Oceania) and NewBridge Pharmaceuticals.

18 Nov 2013

M1T invests $3.4 million in Cloud Medical

M1T, an American business active in the Health Care industry, has made an investment of $3.4 Million in Cloud Medical, completing the company series A round. Cloud is a Healthcare IT company focused on deploying hardware and software systems that will minimize inefficiencies related to compliance and auditing, giving providers more control over medical procedures, processes and records.

16 Nov 2013

Kindred Healthcare to acquire Synergy Home Care

Synergy Home Care, a premier home health care provider that operates through 17 locations in Louisiana, has signed a definitive agreement to be acquired by Kindred Healthcare, Inc. The transaction is expected to close in the fourth quarter of 2013, pending regulatory approvals and other customary conditions.

16 Nov 2013

ZOLL Medical announces establishment of ZOLL Foundation

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today the establishment of the ZOLL Foundation, an independent entity organized for scientific and educational purposes.

16 Nov 2013

GoInformatics, TeselaGen form strategic partnership to offer cutting-edge biodesign automation tools

GoInformatics and TeselaGen have announced a strategic partnership to offer a state-of-the-art Biological Design Automation and Scientific Data Management platform. With a secure repository to collect, organize, and store research information, the integrated cloud-based platform will enable scientists advance their research at a much faster pace.

16 Nov 2013

CHEST, Chinese Thoracic Society partner to unify specialties of pulmonary and critical care in China

The American College of Chest Physicians and the Chinese Thoracic Society have formally agreed to collaborate to develop and launch fellowship programs in pulmonary and critical care medicine in China.

15 Nov 2013

WuXi PharmaTech subsidiary enters into supply arrangement with Pharmacyclics

WuXi PharmaTech, a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced that its wholly owned subsidiary Shanghai SynTheAll Pharmaceutical Co., Ltd., has entered into a supply arrangement with Pharmacyclics, Inc.

15 Nov 2013

Designation of ISIS-GSK4Rx as a development candidate triggers milestone payment to Isis

Isis Pharmaceuticals, Inc. announced today that it has earned a $5 million milestone payment from GlaxoSmithKline related to the designation of ISIS-GSK4Rx as a development candidate. ISIS-GSK4Rx is an antisense drug designed to treat an undisclosed ocular disease.

15 Nov 2013

Business / Finance

Ansell reaches agreement to acquire BarrierSafe Solutions International

CHMP adopts positive opinion for ABRAXANE with gemcitabine for treatment of metastatic pancreas

Nutranomics joins Genesar Nutraceuticals to acquire worldwide licence for GenEpic

Patient Safety Technologies announces closing of $5 million senior secured term loan

Covagen, TRL expand research collaboration to generate bispecific FynomAb

Vect-Horus, AAA form scientific collaboration to open new avenues in treatment of brain diseases

RAS, Sutter Health join to provide medical care and services for patients in greater Sacramento region

LabStyle Innovations, InnoMed ink distribution agreement for Dario blood glucose monitoring device

AGA, Covidien partner to improve lives of people struggling with digestive diseases

Curie-Cancer inks partnership agreements with Meiogenix to develop SpiX technology

New range of recombinant Fab monoclonal antibodies launched by BBI Solutions at Medica 2013

Argos Soditic-managed funds announce acquisition of Cisbio Bioassays

Eisai partners with NewBridge Pharmaceuticals to market Halaven drug in Middle East

M1T invests $3.4 million in Cloud Medical

Kindred Healthcare to acquire Synergy Home Care

ZOLL Medical announces establishment of ZOLL Foundation

GoInformatics, TeselaGen form strategic partnership to offer cutting-edge biodesign automation tools

CHEST, Chinese Thoracic Society partner to unify specialties of pulmonary and critical care in China

WuXi PharmaTech subsidiary enters into supply arrangement with Pharmacyclics

Designation of ISIS-GSK4Rx as a development candidate triggers milestone payment to Isis

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News